This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Banks At Risk of a Commercial Real Estate Double Dip

3. Synovus Financial

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Shares of Georgia-based Synovus (SNV - Get Report) are down 20% year to date.

Synovus had a commercial real estate exposure of $11.5 billion as of the March 31, 2011, about 330% of its core capital. Non-performing CRE loans accounted for about 20% of its core capital.

Synovus is exposed to the SouthEast where real estate has taken the worst hit. Georgia and Florida, accounted for about approximately 53% and 13% of the total loan portfolio by geographic concentration.

JPMorgan analysts said in a note in May that Synovus is "likely to remain challenged on the growth front given a remixing of the loan portfolio away from C&D (construction and development) loans and more into C&I(commercial and industrial). In the first quarter, average loans declined at a 15% annualized pace. With the market seemingly very focused on top-line organic growth potential, we believe it's unlikely the market will take a more favorable view of SNV's growth prospects over the near term," the analysts wrote.

Wunderlich Securities recently downgraded the stock to a hold, citing capital constraints." We believe that Synovus' earnings power beyond this credit cycle will be greatly constrained by the potential need to raise significant amounts of common equity in order to exit the TARP program," the analyst wrote in a note.

Out of the 29 analysts covering the stock, four have a buy rating, 21 a hold rating and four have a sell call on the stock.
4 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
BPOP $30.06 4.16%
BXS $26.11 1.36%
FBP $4.89 1.45%
SNV $31.03 0.68%
AAPL $126.60 0.94%

Markets

DOW 17,757.91 +138.40 0.79%
S&P 500 2,077.42 +14.31 0.69%
NASDAQ 5,013.1230 +26.2560 0.53%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs